Fuminori Yoshida
Founder at SYMBIO PHARMACEUTICALS LIMITED
Net worth: 1 M $ as of 30/04/2024
Fuminori Yoshida active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Director/Board Member | 25/03/2005 | - |
| Chief Executive Officer | 25/03/2005 | - | |
| Founder | 25/03/2005 | - | |
| President | 25/03/2005 | - |
Career history of Fuminori Yoshida
Former positions of Fuminori Yoshida
| Companies | Position | Start | End |
|---|---|---|---|
| Syntex Japan Co., Ltd. | Corporate Officer/Principal | 01/01/1993 | 15/09/2009 |
| President | 15/09/2009 | - | |
| AHS Japan, Inc. | Corporate Officer/Principal | - | - |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Founder | 01/01/1993 | - |
| President | 01/01/1993 | - | |
| MITSUBISHI CORPORATION | Corporate Officer/Principal | - | - |
| Nippon Bio-Rad Laboratories | Founder | 03/08/2009 | - |
| President | 03/08/2009 | - |
Training of Fuminori Yoshida
| Massachusetts Institute of Technology | Graduate Degree |
| Harvard University | Graduate Degree |
| Gakushuin University | Undergraduate Degree |
Statistics
International
| Japan | 8 |
| United States | 3 |
Operational
| President | 4 |
| Founder | 3 |
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
| MITSUBISHI CORPORATION | Distribution Services |
| Private companies | 4 |
|---|---|
| Nippon Bio-Rad Laboratories | |
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
| AHS Japan, Inc. | |
| Syntex Japan Co., Ltd. |
- Stock Market
- Insiders
- Fuminori Yoshida
- Experience
